Fatih Karakaya

Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV‐1 study

Cihan Yurdaydın, Onur Keskın, Çağdaş Kalkan et al. · Hepatology · 2017 · 145 citations

Diet affects gut microbiota and modulates hospitalization risk differentially in an international cirrhosis cohort

Jasmohan S. Bajaj, Ramazan Idılman, Leila Mabudian et al. · Hepatology · 2018 · 117 citations

Interferon Treatment Duration in Patients With Chronic Delta Hepatitis and its Effect on the Natural Course of the Disease

Cihan Yurdaydın, Onur Keskın, Çağdaş Kalkan et al. · The Journal of Infectious Diseases · 2018 · 89 citations · Full text

A phase 2 dose‐finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis

Cihan Yurdaydın, Onur Keskın, Esra Yurdcu et al. · Hepatology · 2021 · 71 citations

Subanalysis of the LOWR HDV-2 study reveals high response rates to Lonafarnib in patients with low viral loads

Çağdaş Kalkan, Fatih Karakaya, Özge Keskin et al. · Journal of Hepatology · 2018 · 19 citations

Thrombosis, Viral Persistence, Viral Hepatitis +8